Synergy of amlodipine and angiotensin-converting enzyme inhibitors in regulating myocardial oxygen consumption in normal canine and failing human hearts

American Journal of Cardiology

Volumn 83, Issue 12 A, 1999, Pages 92-98

  Mital, Seema ^a   Loke, Kit E ^b   Slater, James P ^a   Addonizio, Linda ^a   Gersony, Welton M ^a   Hintze, Thomas H ^c  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICATIBANT; ISOCOUMARIN DERIVATIVE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; RAMIPRILAT; SERINE PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SCHOOL CHILD; TISSUE OXYGENATION;

EID: 0033577955     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00269-6     Document Type: Conference Paper

References (28)

1. Wall T., Linseman D., Shebuski R., Hartman J. Ramiprilat and des-arg bradykinin attenuate hypoxic injury in isolated cardiac myocytes. FASEB J. 7:1993;691.
2. Scholkens B.A., Linz W., Konig W. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist. J Hypertens. 6:1988;S25-S28.
3. Westlin W., Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation. 77:(suppl 1):1988;30-39.
4. Baumgarten C.R., Linz W., Kunkel G., Scholkens B.A., Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 108:1993;293-295.
5. Bhoola K.D., Figueroa C.D., Worthy K. Bioregulation of kinins kallikreins, kininogens, kininases . Pharmacol Rev. 44:1992;1-80.
6. Wiemer G., Scholkens B.A., Becker R.H.A., Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension. 18:1991;558-563.
7. Brown G.C. Nitric oxide regulates mitochondrial respiration and cell function by inhibiting cytochrome oxidase. FEBS Lett. 369:1995;136-139.
8. Zhang X., Xie Y.-W., Nasjletti A., Xu X., Wolin M., Hintze T.H. ACE inhibitors promote nitric oxide accumulation to modulate myocardial oxygen consumption. Circulation. 95:1997;176-182.
9. Kichuk M.R., Zhang X., Oz M., Michler R., Kaley G., Nasjletti A., Hintze T.H. ACE inhibitors promote nitric oxide production in coronary microvessels from failing explanted human hearts. Am J Cardiol. 80:1997;137A-142A.
10. Smith C.J., Sun D., Hoegler C., Roth B.S., Zhang X., Zhao G., Xu X., Kobari Y., Pritchard K., Sessa W.C., Hintze T.H. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res. 78:1996;58-64.
11. Packer M., O'Connor C.M., Ghali J.K., Pressler M.L., Carson P.E., Belkin R.N., Miller A.B., Neuberg G.W., Frid D., Wertheimer J.H., Cropp A.B., DeMets D.L. Effects of amlodipine on morbidity and mortality in severe chronic heart failure Prospective Randomized Amlodipine Survival Evaluation Study Group . N Engl J Med. 335:1996;1107-1114.
12. Zhang X., Hintze T.H. Amlodipine releases nitric oxide from canine coronary microvessels an unexpected mechanism of action of a calcium channel-blocking agent . Circulation. 97:1998;576-580.
13. Pool P.E., Sonnenblick E.H. The mechanochemistry of cardiac muscle. J Gen Physiol. 50:1971;951-956.
14. Bernstein R.D., Ochoa F.Y., Xu X., Forfia P., Shen W., Thompson C.I., Hintze T.H. Function and production of nitric oxide in the coronary circulation of the conscious dog during exercise. Circ Res. 79:1996;840-848.
15. Shen W., Xu X., Ochoa M., Zhao G., Wolin M.S., Hintze T.H. Role of nitric oxide in the regulation of oxygen consumption in conscious dogs. Circ Res. 75:1994;1086-1095.
16. Linz W., Weimer G., Gohlke P., Unger T., Scholdens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Am Soc Pharmacol Exp Ther. 47:1995;25-49.
17. Muller-Estrl W. Kininogen, kinins and kinships. Thromb Haemost. 61:1989;2-6.
18. Xie Y.-W., Shen W., Zhao G., Xu X., Wolin M.S., Hintze T.H. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure. Circ Res. 79:1996;381-387.
19. Treasure C.B., Vita J.A., Cox D.A., Fish R.D., Gordon J.B., Mudge G.H., Colucci W.S., St John Sutton M.G., Selwyn A.P., Alexander R.W., Ganz P. Endothelium-dependent dilation of coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
20. Katz S.D., Schwarz M., Yuen J., Lejemtel T.H. Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure role of endothelium-derived vasodilating and vasoconstricting factors . Circulation. 88:1993;55-61.
21. Kubo S.H., Rector T.S., Bank A.J., William R.E., Heifetz S.M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 84:1991;1589-1596.
22. Zhao G., Shen W., Xu X., Ochoa M., Bernstein R., Hintze T.H. Selective impairment of vagally-mediated, nitric oxide-dependent coronary vasodilation in conscious dogs after pacing-induced heart failure. Circulation. 91:1995;2655-2663.
23. Elkayan U., Amin J., Mehra A., Vasquez J., Weber L., Rahimtoola S.H. A prospective, randomized, double-blind, cross-over study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of congestive heart failure. Circulation. 82:1990;1954-1961.
24. Goldstein R.E., Bocuzzi S.J., Cruess D., Nattel S. Diltiazem increases late onset congestive heart failure in post infarction patients with early reduction in ejection fraction. Circulation. 83:1991;52-60.
25. Littler W.A., Sheridan D.J. Placebo-controlled trial of felodipine in patients with mild to moderate heart failure: UK Study Group. Br Heart J. 71:1995;428-433.
26. Hare J.M., Keaney J.F., Balligand J.L., Loscalzo J., Smith T.M. Role of nitric oxide in parasympathetic modulation of β-adrenergic myocardial contractility in normal dogs. J Clin Invest. 95:1995;360-366.
27. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
28. Kanai A.J., Mesaros S., Finkel M.S., Oddis C.V., Birder L.A., Malinski T. β-Adrenergic regulation of constitutive nitric oxide synthase in cardiac myocytes. Am J Physiol. 273:1997;C1371-C1377.